The origin and properties of extracellular DNA: from PAMP to DAMP

DS Pisetsky - Clinical Immunology, 2012 - Elsevier
DNA is a polymeric macromolecule whose biological activities depend on location as well
as binding to associated molecules. Inside the cell, DNA is the source of genetic information …

Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis

FG Goh, KS Midwood - Rheumatology, 2012 - academic.oup.com
RA is a debilitating disorder that manifests as chronic localized synovial and systemic
inflammation leading to progressive joint destruction. Recent advances in the molecular …

Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity

KN Townsend, LRK Hughson, K Schlie… - Immunological …, 2012 - Wiley Online Library
Tumors and the immune system are intertwined in a competition where tilting the fine
balance between tumor‐specific immunity and tolerance can ultimately decide the fate of the …

Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells

J Kim, MLR Yip, X Shen, H Li, LYC Hsin, S Labarge… - PLoS …, 2012 - journals.plos.org
Despite recent advances in targeted therapies, patients with pancreatic adenocarcinoma
continue to have poor survival highlighting the urgency to identify novel therapeutic targets …

Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research

A Yuri Gasparyan, L Ayvazyan… - Current …, 2012 - ingentaconnect.com
Clinical manifestations of most rheumatic diseases have changed over the past few
decades, largely due to advances in therapies targeting autoimmune and (auto) …

Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort

GJ Pons-Estel, GS Alarcón, L Hachuel, G Boggio… - …, 2012 - academic.oup.com
Objective. To examine the role of ethnicity and the use of anti-malarials (protective) on lupus
renal disease. Methods. A nested case–control study (1: 2 proportion, n= 265 and 530) …

Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases

PM Clark, N Dawany, W Dampier… - Inflammatory bowel …, 2012 - academic.oup.com
Background Inflammatory bowel disease (IBD) is a complex disorder involving pathogen
infection, host immune response, and altered enterocyte physiology. Incidences of IBD are …

Evidence for risk of cardiomyopathy with hydroxychloroquine

MD Sumpter, LS Tatro, WV Stoecker, RK Rader - Lupus, 2012 - journals.sagepub.com
Sir, Hydroxychloroquine (HCQ) is a disease-modifying antirheumatic drug used in the
treatment of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). 1–3 SLE …

Decrease in circulating DNA, IL-10 and BAFF levels in newly-diagnosed SLE patients after corticosteroid and chloroquine treatment

AM Cepika, DS Jureša, JM Vergles, B Malenica… - Cellular …, 2012 - Elsevier
Arsenal of pattern-recognition receptors alongside antibody production machinery make B
cells vulnerable to autoimmune response if an autoantigen elicits both pathways in a self …

Discovering thiamine transporters as targets of chloroquine using a novel functional genomics strategy

Z Huang, S Srinivasan, J Zhang, K Chen, Y Li… - PLoS …, 2012 - journals.plos.org
Chloroquine (CQ) and other quinoline-containing antimalarials are important drugs with
many therapeutic benefits as well as adverse effects. However, the molecular targets …